Coronavirus (COVID-19) has had a significant impact on credit conditions and levels of uncertainty. As a result, banks’ processes for estimating IFRS 9 expected credit losses (ECLs) have had to adapt. In this publication, we provide the top 10 questions about ECLs that we believe audit committees and CFOs of banks should be asking now.
What are the key performance indicators (KPIs) used to evaluate ECLs, how will we assess their continued appropriateness in the current environment, and how do they (and underlying assumptions) compare to peers? (see In the Spotlight: Understanding expected credit losses – what metrics might help?)
How does our ECL compare to our annual internal budget for credit losses; and, given that IFRS 9 is already forward-looking, can any significant differences be explained?
How have we compared ECLs with current and past capital metrics (for example, losses in stressed scenarios) to understand potential inconsistencies and capital impacts over time?
What temporary or permanent changes to our ECL processes, governance and internal controls are being made as a result of COVID-19?
To what extent will third parties be involved in determining or assessing the ECL (for example, external model validation, third-party data, and models), and what internal oversight is already, or will be, in place?
What information about ECLs will we disclose, and is it in line with our peers’ disclosures and regulatory expectations?
What questions about IFRS 9 have investors, analysts and regulators asked in the past, what new questions do we anticipate them having, and what are we doing proactively to address them?
What management information is being produced internally and how is it communicated to ensure it is used in a consistent manner throughout the organisation (for example, using tools such as Tableau, Microsoft Power BI or R Shiny)?